[1]
Y. Miura, “Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 31, no. 3, pp. 235–238, Oct. 2014, Accessed: Jul. 04, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/3326